  | Mobasheri, A., Reginster, J.-Y., Chandran, M., & McSwan, J. (2025). Bone health and pregnancy: Osteoporosis and beyond. Case Reports in Women's Health, 00725. doi:10.1016/j.crwh.2025.e00725  Peer Reviewed verified by ORBi |
 | Hannani, M. T., Thudium, C. S., Gellhorn, A. C., Larkin, J., Karsdal, M. A., Lisowska-Petersen, Z., Frederiksen, P., Bager, C. L., Ladel, C., Struglics, A., Uebelhoer, M., Henrotin, Y., Bihlet, A. R., Blanco, F. J., Haugen, I. K., Kloppenburg, M., Berenbaum, F., Mobasheri, A., Bacardit, J., & Bay-Jensen, A.-C. (January 2025). Longitudinal stability of molecular endotypes of knee osteoarthritis patients. Osteoarthritis and Cartilage, 33 (1), 166 - 175. doi:10.1016/j.joca.2024.11.002 Peer Reviewed verified by ORBi |
 | Ng, K., Ellis, R., Mobasheri, A., & Reginster, J.-Y. (December 2024). Why Did the "Five-Year Incidence of Progression to Osteoarthritis and Total Joint Arthroplasty in Patients Prescribed Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists" Differ From Previous Randomized Controlled Study? Journal of Arthroplasty, 39 (12), 68 - e69. doi:10.1016/j.arth.2024.08.035 Peer Reviewed verified by ORBi |
 | Fuggle, N. R., Beaudart, C., Bruyère, O., Abrahamsen, B., Al-Daghri, N., Burlet, N., Chandran, M., Rosa, M. M., Cortet, B., Demonceau, C., Dere, W., Halbout, P., Hiligsmann, M., Kanis, J. A., Kaufman, J.-M., Kurth, A., Lamy, O., Laslop, A., Maggi, S., ... Harvey, N. C. (14 March 2024). Evidence-Based Guideline for the management of osteoporosis in men. Nature Reviews Rheumatology, 20 (4), 241-251. doi:10.1038/s41584-024-01094-9 Peer Reviewed verified by ORBi |
 | Ladang, A., Beaudart, C., Reginster, J.-Y., Al-Daghri, N., Bruyère, O., Burlet, N., Cesari, M., Cherubini, A., da Silva, M. C., Cooper, C., Cruz-Jentoft, A. J., Landi, F., Laslop, A., Maggi, S., Mobasheri, A., Ormarsdottir, S., Radermecker, R., Visser, M., Yerro, M. C. P., ... Cavalier, E. (September 2023). Correction: Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging. Calcified Tissue International, 113 (3), 357 - 358. doi:10.1007/s00223-023-01114-y Peer Reviewed verified by ORBi |
 | Veronese, N., Cooper, C., Bruyère, O., Al-Daghri, N., Branco, J., Cavalier, E., Cheleschi, S., da Silva Rosa, M. C., Conaghan, P. G., Dennison, E. M., de Wit, M., Fioravanti, A., Fuggle, N. R., Haugen, I. K., Herrero-Beaumont, G., Honvo, G., Laslop, A., Matijevic, R., Migliore, A., ... Reginster, J.-Y. (16 September 2022). Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations. Drugs, 82 (13), 1347-1355. doi:10.1007/s40265-022-01773-5 Peer Reviewed verified by ORBi |
 | Arden, N., Perry, T. A., Bannuru, R. R., Bruyère, O., Cooper, C., Haugen, I. K., Hochberg, M. C., McAlindon, T. E., Mobasheri, A., & Reginster, J.-Y. (2022). How can we explain the differences between the OARSI and ESCEO Guidelines for the management of knee osteoarthritis? Osteoporosis International, 32 (Suppl 1), 57-58. Peer Reviewed verified by ORBi |
 | Honvo, G., Reginster, J.-Y., Mobasheri, A., Lengele, L., Avouac, B., Rizzoli, R., & Bruyère, O. (2022). Post-marketing safety surveillance of anti-osteoarthritis drugs: a protocol for a systematic review of published literature. Osteoporosis International, 32 (Suppl 1), 242-243. Peer Reviewed verified by ORBi |
